Drug-loaded microbubble delivery system to enhance PD-L1 blockade immunotherapy with remodeling immune microenvironment

被引：0
|
作者：
Jun Zheng
Ju Huang
Liang Zhang
Mengna Wang
Lihong Xu
Xiaoyun Dou
Xiaojing Leng
Mingxiao Fang
Yang Sun
Zhigang Wang
机构：
[1] The Second Affiliated Hospital,State Key Laboratory of Ultrasound in Medicine and Engineering, Institute of Ultrasound Imaging
[2] Chongqing Medical University,Ultrasound Department
[3] The First Affiliated Hospital of Chongqing Medical University,Department of Pathology, College of Basic Medicine
[4] Chongqing Medical University,Institute of Life Sciences
[5] Chongqing Medical University,undefined
来源：
Biomaterials Research | / 27卷
关键词：
Ultrasound-targeted microbubble destruction (UTMD); Immune checkpoint blockade (ICB); Docetaxel (DTX); PD-L1; Tumor immunosuppressive microenvironment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
    Zamarin, Dmitriy
    Ricca, Jacob M.
    Sadekova, Svetlana
    Oseledchyk, Anton
    Yu, Ying
    Blumenschein, Wendy M.
    Wong, Jerelyn
    Gigoux, Mathieu
    Merghoub, Taha
    Wolchok, Jedd D.
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (04): : 1413 - 1428
  • [22] Application prospect of peptide-modified nano targeting drug delivery system combined with PD-1/PD-L1 based immune checkpoint blockade in glioblastoma
    Song, Panpan
    Zhao, Xia
    Xiao, Sa
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 589
  • [23] Unleashing the immune system: PD-1 and PD-Ls in the pre-treatment tumor microenvironment and correlation with response to PD-1/PD-L1 blockade
    Taube, Janis M.
    ONCOIMMUNOLOGY, 2014, 3 (11): : e963413 - 1
  • [24] Development of cancer immunotherapy based on PD-1/PD-L1 pathway blockade
    Zhang, Min
    Liu, Kehai
    Wang, Mingfu
    RSC ADVANCES, 2019, 9 (58) : 33903 - 33911
  • [25] Current status of PD-1/PD-L1 blockade immunotherapy in breast cancer
    Noguchi, Emi
    Shien, Tadahiko
    Iwata, Hiroji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (03) : 321 - 332
  • [26] Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
    Hsu, Joy
    Hodgins, Jonathan J.
    Marathe, Malvika
    Nicolai, Chris J.
    Bourgeois-Daigneault, Marie-Claude
    Trevino, Troy N.
    Azimi, Camillia S.
    Scheer, Amit K.
    Randolph, Haley E.
    Thompson, Thornton W.
    Zhang, Lily
    Iannello, Alexandre
    Mathur, Nikhita
    Jardine, Karen E.
    Kirn, Georgia A.
    Bell, John C.
    McBurney, Michael W.
    Raulet, David H.
    Ardolino, Michele
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (10): : 4654 - 4668
  • [27] Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
    Xin Wang
    Gaochao Guo
    Hui Guan
    Yang Yu
    Jie Lu
    Jinming Yu
    Journal of Experimental & Clinical Cancer Research, 38
  • [28] Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
    Wang, Xin
    Guo, Gaochao
    Guan, Hui
    Yu, Yang
    Lu, Jie
    Yu, Jinming
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [29] Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer
    Wang, Man
    Zhu, Lijie
    Yang, Xiaoxu
    Li, Jiahui
    Liu, Yu'e
    Tang, Ying
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [30] Crosstalk Between PD-1/PD-L1 Blockade and Its Combinatorial Therapies in Tumor Immune Microenvironment: A Focus on HNSCC
    Lin, Weimin
    Chen, Miao
    Hong, Le
    Zhao, Hang
    Chen, Qianming
    FRONTIERS IN ONCOLOGY, 2018, 8
12345